Proven To Lower Blood Pressure In 10 Clinical Studies
RESPeRATE is the only non-drug therapy that has been clinically proven over and over again to lower blood pressure.
The clinical studies on RESPeRATE have been published in numerous peer-reviewed publications including The American Journal of Hypertension and the American Heart Association Hypertension Primer.
Clinical Trials Overview
Graph 1: Patients using RESPeRATE experienced a significant and sustained reduction in blood pressure within 3-4 weeks
The Blood Pressure Lowering Results Demonstrated by RESPeRATE
Graph 2: RESPeRATE lowers high blood pressure by up to 36 points systolic and 20 points diastolic (top 10% reductions), as shown in seven separate clinical trials with average reductions of 14/8 points.
- Dr. Joseph Marek, Midwest Heart Specialists; Downers Grove, IL.
RESPeRATE Information Kit
Download a PDF Brochure for You and Your Doctor.
Dr. Henry Black, New York
President Am. Soc. of Hypertension
How he uses RESPeRATE in clinical practice.
Scientific Advisory Board
InterCure's exceptionally strong scientific underpinning and its unique technology has attracted the support of many of the world's leading experts in hypertension and other cardiovascular diseases.
Henry Black, M.D.
Dr. Black is a board-certified nephrologist with nearly three decades of experience in preventive cardiology. Dr. Black received his training at Johns Hopkins Medical Center.
Jay Cohn, M.D.
Dr. Cohn was instrumental in developing the concept of vasodilator therapy for heart failure and has organized and chaired the Veterans Affairs Cooperative Study Program on vasodilator therapy of heart failure. Dr. Cohn was one of the first to advocate bedside hemodynamic monitoring in acutely ill individuals, was the first to identify the syndrome of right ventricular infarction, and was the first to identify vasodilator drugs as an effective therapy for acute and chronic heart failure.
Ehud Grossman, M.D.
Professor Grossman graduated from the Medical School of Tel-Aviv University and then served as a physician in the Israeli army. After training in internal medicine and hypertension, he worked with Professor ED Frohlich and Professor FH Messerli at Ochsner Clinic in New Orleans on hemodynamic changes in hypertension. He also worked with Harry Keiser and David Goldstein at the National Institute of Health on the relationship between the sympathetic nervous system and hypertension.
Joseph L. Izzo, M.D.
Dr. Izzo is one of the world's most prominent opinion leaders in hypertension and has published extensively in areas such as the mechanisms of hypertension and stress responses of blood pressure, the mechanisms of endothelial dysfunction and exaggerated vasoreactivity, cellular and physiologic control of sympathetic nerve activity, and arterial compliance and vascular biomechanics.
Giuseppe Mancia, M.D.
Dr. Mancia served as President (1988-1990) and Secretary (1984-1988) of the International Society of Hypertensionds (ISH). He has also served as President of the European Society of Clinical Investigation (1980-1982), President of the Italian Society of Hypertension (1997-1999) and is past President of the European Society of Hypertension (ESH), and member 'ex officio' of the Executive Scientific Council of the American Society of Hypertension.
Michael Weber, M.D.
Dr. Weber is a Fellow of the Council for High Blood Pressure Research of the American Heart Association, the American College of Cardiology, and the American College of Clinical Pharmacology. He is the immediate past president of the American Society of Hypertension and an editor of the American Journal of Hypertension. He currently serves as a consultant to the Center for Drug Evaluation and Research of the FDA.
RESPeRATE Peer-Reviewed Articles(All links open in a new window)
|1.||"Treating hypertension with a device that slows and regularizes breathing: A randomised, double-blind controlled study." Schein M, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, Zlotnikov E, Ben-Zvi N, Melmed RN. Journal of Human Hypertension; 2001, 15:271-278.|
|2.||"Breathing-control lowers blood pressure." Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Journal of Human Hypertension; 2001, 15:263-269.|
|3.||"Device-guided breathing exercises reduce blood pressure - Ambulatory and home measurements." Rosenthal T, Alter A, Peleg E, Gavish B.American Journal of Hypertension; 2001, 14:74-76.|
|4.||"Nonpharmacologic Treatment of Hypertension by Respiratory Exercise in the Home Setting." E Meles, C Giannattasio, M Failla, G Gentile, A Capra, G Mancia. American Journal of Hypertension; 2004, 17:370-374.|
|5.||"Graded Blood Pressure Reduction in Hypertensive Outpatients Associated with Use of a Device to Assist with Slow Breathing." W Elliott, J Izzo, Jr., WB White, D Rosing, CS Snyder, A Alter, B Gavish, HR Black. J Clin Hypertens; 2004 6(10): 553-559.|
|6.||"Non-Pharmacological Treatment of Resistant Hypertensives by Device-Guided Slow Breathing Exercises." Viskoper , R, Shapira, I, Priluck, R, Mindlin, R, Chornia, L, Laszt, A, Dicker, D, Gavish, B, Alter, A. American Journal of Hypertension; 2003; 16:484-487.|
|7.||"High Blood Pressure Reduction in Diabetics with Interactive Device-Guided Paced Breathing: Final Results of a Randomized Controlled Study." MH Schein, A Alter, S Levine, T Baevsky, A Nessing, and B Gavish. Journal of Hypertension 2007; 25 (2), S192.|
|8.||"Blood pressure change following 8-week, 15-minute daily treatment with paced breathing guided by a device: A korean multi-center study." J H Bae, J H Kim, K H Choe, S P Hong, K S Kim, C H Kim and W H Kim. Journal of Clinical Hypertension, 2006, 8 (5), A43.|
|9.||"Device-Guided Paced Breathing Reduces Blood Pressure: Ambulatory and Office Measurements." Aydin et al. European Society of Hypertension 2008. [in print]|
|10.||"Device-Guided Breathing to Lower Blood Pressure: Case Report and Clinical Overview." W Elliott, J Izzo Medscape General Medicine, 2006; 8(3) - (Requires free registration to read the complete article.)|
|11.||Meles E, Giannattasio G, Boff L et al. Italian Society of Hypetension National Meeting, Bologna Italy, September 2002.|